Signal A global pharma company simulates enrollment and diversity targets on a clinical-trial digital twin

Summary

The pharma use case describes an unnamed global pharmaceutical company building a clinical-trial digital twin from protocol design, historical trial data, real-world evidence and site performance, simulating enrollment curves, diversity targets, site risk and protocol deviations before first patient in, and updating the twin from live data to recommend backup sites or schedule changes.